Factors associated with immunization against hepatitis B among primary health care professionals

• Published in: Revista brasileira de medicina do trabalho 2022-10, Vol.20 (4), p.563-573
• Main Authors: Mota, Gabrielly Alves, Fernandes, Lara Vívian Paixão, Fonseca, Luana Alkmim, Ferreira, Maria Izabel de Azevedo, Mendes, Vitor Lucas Bonfim, Lima, Carlos Roberto Santos, Cardoso, Anamaria de Souza
• Format: Article
• Language: English
• Subjects: Original
• ISSN: 1679-4435; 2447-0147
• DOI: 10.47626/1679-4435-2022-790

The hepatitis B virus is the cause of one of the major public health problems worldwide. The infection may affect the entire population equally; however, health care professionals are part of a group that is more vulnerable to the disease, since they are exposed to both occupational and daily hazards. To investigate the prevalence and factors associated with the immunization of health care professionals against the hepatitis virus type B, in the city of Montes Claros, state of Minas Gerais, Brazil. This was a cross-sectional and quantitative study, conducted with primary health care professionals. Using a random cluster sampling, 209 medical professionals, nurses, and nursing technicians who were interested in participating in the research were selected. A structured questionnaire was applied, and blood sampling was performed for the analysis of hepatitis B surface antibody titers. Finally, a descriptive and bivariate statistical analysis was conducted. Data have shown that 91.8% of the professionals had complete immunization against the hepatitis B virus, that is, they had taken the three recommended doses of the vaccine. However, 13.9% of the sample, even after vaccination, was non-reactive (titers < 10 IU/mL hepatitis B surface antibody). Most of the professionals (94.3%) had direct contact with needlesticks/sharps at work and none of the participants reported a previous infection by the virus. Although most participants had complete immunization, the total result of individuals who did not obtain seroconversion was eminent, so the importance of the hepatitis B surface antibody test must be disseminated in the context of public health.